Progesterone, BDNF and neuroprotection in the injured CNS

International Journal of Neuroscience

Volumn 119, Issue 10, 2009, Pages 1718-1740

  Coughlan, Teresa ^a   Gibson, Claire ^b   Murphy, Sean ^c  

^a UNIVERSITY OF SHEFFIELD   (United Kingdom)

^b UNIVERSITY OF LEICESTER   (United Kingdom)

^c UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

Author keywords

BDNF; Neuroprotection; Progesterone; Stroke

Indexed keywords

BRAIN DERIVED NEUROTROPHIC FACTOR; CYTOKINE; GLUTAMIC ACID; PROGESTERONE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRAIN ISCHEMIA; CELL PROTECTION; CELL VIABILITY; CENTRAL NERVOUS SYSTEM DISEASE; CEREBELLUM; CONTROLLED STUDY; GLIOMA CELL; GRANULAR CELL; MALE; MOUSE; NERVE CELL; NEUROMODULATION; NEUROPROTECTION; NONHUMAN; PROTEIN EXPRESSION; UPREGULATION;

ANIMALS; ANIMALS, NEWBORN; BRAIN-DERIVED NEUROTROPHIC FACTOR; CELL SURVIVAL; CELLS, CULTURED; CEREBELLUM; CYTOKINES; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; GENE EXPRESSION REGULATION; INFARCTION, MIDDLE CEREBRAL ARTERY; MALE; MICE; MICE, INBRED C57BL; NEURONS; PC12 CELLS; PROGESTERONE; PROGESTINS; RATS; TIME FACTORS;

EID: 70350452763     PISSN: 00207454     EISSN: 15635279     Source Type: Journal    
DOI: 10.1080/00207450903116430     Document Type: Article

References (100)

1. Alkayed, N. J., Murphy, S. J., Traystman, R. J., Hurn, P. D., & Miller, V. M. (2000). Neuroprotective effects of female gonadal steroids in reproductively senescent female rats. Stroke, 31, 161-168.
2. Almeida, R. D., Manadas, B. J., Melo, C. V., Gomes, J. R., Mendes, C. S., Graos, M. M., et al. (2005). Neuroprotection by BDNF against glutamate-induced apoptotic cell death is mediated by ERK and PI3-kinase pathways. Cell Death and Differentiation, 12, 1329-1343.
3. Anderson, K. D., Panayotatos, N., Corcoran, T. L., Lindsay, R. M., & Wiegand, S. J. (1996). Ciliary neurotrophic factor protects striatal output neurons in an animal model of Huntington disease. Proceedings of the National Academy of Sciences USA, 93, 7346-7351.
4. Ardeshiri, A., Kelley, M. H., Korner, I. P., Hurn, P. D., & Herson, P. S. (2006). Mechanism of progesterone neuroprotection of rat cerebellar Purkinje cells following oxygen-glucose deprivation. The European Journal of Neuroscience, 24, 2567-2574.
5. Azoulay, D., Urshansky, N.,&Karni, A. (2008). Low and dysregulated BDNF secretion from immune cells of MS patients is related to reduced neuroprotection. Journal of Neuroimmunology, 195, 186-193.
6. Bemelmans, A. P., Husson, I., Jaquet, M., Mallet, J., Kosofsky, B. E., & Gressens, P. (2006). Lentiviral-mediated gene transfer of brain-derived neurotrophic factor is neuroprotective in a mouse model of neonatal excitotoxic challenge. Journal of Neuroscience Research, 83, 50-60.
7. Berger, C., Schabitz, W. R., Wolf, M., Mueller, H., Sommer, C., & Schwab, S. (2004). Hypothermia and brain-derived neurotrophic factor reduce glutamate synergistically in acute stroke. Experimental Neurology, 185, 305-312.
8. Bessho, Y., Nakanishi, S., & Nawa, H. (1993). Glutamate receptor agonists enhance the expression of BDNF mRNA in cultured cerebellar granule cells. Molecular Brain Research, 18, 201-208.
9. Betz, A. L., Yang, G. Y., & Davidson, B. L. (1995). Attenuation of stroke size in rats using an adenoviral vector to induce over expression of interleukin-1 receptor antagonist in brain. Journal of Cerebral Blood Flow and Metabolism, 15, 547-551.
10. Bifrare, Y. D., Kummer, J., Joss, P., Tauber, M. G., & Leib, S. L. (2005). Brain-derived neurotrophic factor protects against multiple forms of brain injury in bacterial meningitis. The Journal of Infectious Diseases, 191, 40-45.
11. Brandoli, C., Sanna, A., De Bernardi, M. A., Follesa, P., Brooker, G., & Mocchetti, I. (1998). Brain-derived neurotrophic factor and basic fibroblast growth factor downregulate NMDA receptor function in cerebellar granule cells. The Journal of Neuroscience, 18, 7953-7961.
12. Brinton, R. D., Thompson, R. F., Foy, M. R., Baudry, M., Wang, J., Finch, C. E., et al. (2008). Progesterone receptors: Form and function in brain. Frontiers in Neuroendocrinology, 29, 313-339.
13. Cahill, M. A. (2007). Progesterone receptor membrane component 1: An integrative review. Journal of Steroid Biochemistry and Molecular Biology, 105, 16-36.
14. Chen, J., Chopp, M., & Li, Y. (1999). Neuroprotective effects of progesterone after transient middle cerebral artery occlusion in rat. Journal of the Neurological Sciences, 171, 24-30.
15. Chen, X., Li, Y., Kline, A. E., Dixon, C. E., Zafonte, R. D., & Wagner, A. K. (2005a). Gender and environmental effects on regional brain-derived neurotrophic factor expression after experimental traumatic brain injury. Neuroscience, 135, 11-17. (Pubitemid 41219734)
16. Chen, J., Zhang, C., Jiang, H., Li, Y., Zhang, L., Robin, A., et al. (2005b). Atorvastatin induction of VEGF and BDNF promotes brain plasticity after stroke in mice. Journal of Cerebral Blood Flow and Metabolism, 25, 281-290.
17. Cheng, Y., Gidday, J. M., Yan, Q., Shah, A. R., & Holtzman, D. M. (1997).Marked agedependent neuroprotection by brain-derived neurotrophic factor against neonatal hypoxic-ischemic brain injury. Annals of Neurology, 41, 521-529.
18. Cheng, B., & Mattson, M. P. (1994). NT-3 and BDNF protect CNS neurons against metabolic/excitotoxic insults. Brain Research, 640, 56-67.
19. Choi, D. W. (1988).Glutamate neurotoxicity and diseases of the nervous system. Neuron, 1, 623-634.
20. Coughlan, T., Gibson, C., & Murphy, S. (2005). Modulatory effects of progesterone on inducible nitric oxide synthase expression in vivo and in vitro. Journal of Neurochemistry, 93, 932-942.
21. Cutler, S. M., Cekic, M., Miller, D. M., Wali, B., Van Landingham, J. W., & Stein, D. G. (2007). Progesterone improves acute recovery after traumatic brain injury in the aged rat. Journal of Neurotrauma, 24, 1475-1486.
22. Danton, G. H., & Dietrich,W. D. (2003). Inflammatory mechanisms after ischemia and stroke. Journal of Neuropathology and Experimental Neurology, 62, 127-136
23. De Nicola, A. F., Gonzalez, S. L., Labombarda, F., Deniselle, M. C., Garay, L., Guennoun, R., et al. (2006). Progesterone treatment of spinal cord injury: Effects on receptors, neurotrophins, and myelination. Journal of Molelcular Neuroscience, 28, 3-15.
24. Dirnagl, U., Iadecola, C.,&Moskowitz, M. A. (1999). Pathobiology of ischaemic stroke: An integrated view. Trends in Neurosciences, 22, 391-397.
25. Dougherty, K. D., Dreyfus, C. F., & Black, I. B. (2000). Brain-derived neurotrophic factor in astrocytes, oligodendrocytes, and microglia/macrophages after spinal cord injury. Neurobiology of Disease, 7, 574-585.
26. Ernfors, P., Bengzon, J., Kokaia, Z., Persson, H., & Lindvall, O. (1991). Increased levels of messenger RNAs for neurotrophic factor in the brain during kindling epileptogenesis. Neuron, 7, 165-176.
27. Ernfors, P., Wetmore, C., Olson, L., & Persson, H. (1990). Identification of cells in rat brain and peripheral tissues expressing mRNA for members of the nerve growth factor family. Neuron, 5, 511-526.
28. Favaron, M., Manev, R. M., Rimland, J. M., Candeo, P., Beccaro, M., & Manev, H. (1993). NMDA-stimulated expression of BDNF mRNA in cultured cerebellar granule neurones. Neuroreport, 4, 1171-1174.
29. Ferńandez-Śanchez, M. T., & Novelli, A. (1993). Basic fibroblast growth factor protects cerebellar neurons in primary culture from NMDA and non-NMDA receptor mediated neurotoxicity. FEBS Letters, 335, 124-131.
30. Franklin, T. B., & Perrot-Sinal, T. S. (2006). Sex and ovarian steroids modulate brain-derived neurotrophic factor (BDNF) protein levels in rat hippocampus under stressful and non-stressful conditions. Psychoneuroendocrinology, 31, 38-48.
31. Friedman, W. J., Olson, L., & Persson, H. (1991). Cells that express brain-derived neurotrophic factor mRNA in the developing postnatal rat brain. European Journal of Neuroscience, 3, 688-697.
32. Galvin, K. A., & Oorschot, D. E. (2003). Continuous low-dose treatment with brain-derived neurotrophic factor or neurotrophin-3 protects striatal medium spiny neurons from mild neonatal hypoxia/ischemia: A stereological study. Neuroscience, 118, 1023-1032.
33. Gibson, C. L., Constantin, D., Prior, M. J. W., Bath, P. M. W., & Murphy, S. P. (2005). Progesterone suppresses the inflammatory response and nitric oxide synthase-2 expression following cerebral ischemia. Experimental Neurology, 193, 522-530.
34. Gibson, C. L., & Murphy, S. P. (2004). Progesterone enhances functional recovery after middle cerebral artery occlusion in male mice. Journal of Cerebral Blood Flow and Metabolism, 24, 805-813.
35. Gonzalez, S. L., Labombarda, F., Gonzalez Deniselle, M. C., Guennoun, R., Schumacher, M., & De Nicola, A. F. (2004). Progesterone up-regulates neuronal brainderived neurotrophic factor expression in the injured spinal cord. Neuroscience, 125, 605-614.
36. Gonzalez, S. L., Labombarda, F., Gonzalez Deniselle,M. C., Mougel, A., Guennoun, R., Schumacher,M., et al. (2005). Progesterone neuroprotection in spinal cord trauma involves up-regulation of brain-derived neurotrophic factor in motoneurons. The Journal of Steroid Biochemistry and Molecular Biology, 94, 143-149.
37. Gonzalez Deniselle, M. C., Garay, L., Gonzalez, S., Saravia, F., Labombarda, F., Guennoun, R., et al. (2007). Progesterone modulates brain-derived neurotrophic factor and choline acetyltransferase in degenerating Wobbler motoneurons. Experimental Neurology, 203, 406-414.
38. Gonzalez Deniselle, M. C., Lopez-Costa, J. J., Saavedra, J. P., Pietranera, L., Gonzalez, S. L., Garay, L., et al. (2002). Progesterone neuroprotection in theWobbler mouse, a genetic model of spinal cord motor neuron disease. Neurobiology of Disease, 11, 457-468.
39. Goodman, Y., Bruce, A. J., Cheng, B., & Mattson, M. P. (1996). Estrogens attenuate and corticosterone exacerbates excitotoxicity, oxidative injury, and amyloid ?-peptide toxicity in hippocampal neurons. Journal of Neurochemistry, 66, 1836-1844. (Pubitemid 26118770)
40. Grossman, K. J., Goss, C. W., & Stein, D. G. (2004). Effects of progesterone on the inflammatory response to brain injury in the rat. Brain Research, 1008, 29-39.
41. Gustafsson, E., Lindvall, O., & Kokaia, Z. (2003). Intraventricular infusion of TrkB-Fc fusion protein promotes ischemia-induced neurogenesis in adult rat dentate gyrus. Stroke, 34, 2710-2715.
42. Han, B. H., & Holtzmann, D. M. (2000). BDNF protects the neonatal brain from hypoxic-ischemic injury in vivo via the ERK pathway. Journal of Neuroscience, 20, 5775-5781.
43. He, J., Hoffman, S. W., & Stein, D. G. (2004). Allopregnanolone, a progesterone metabolite, enhances behavioral recovery and decreases neuronal loss after traumatic brain injury. Restorative Neurology and Neuroscience, 22, 19-31.
44. Hofer, M., Pagliusi, S. R., Hohn, A., Leibrock, J., & Barde, Y. A. (1990). Regional distribution of brain-derived neurotrophic factor mRNA in the adult mouse brain. The EMBO Journal, 9, 2459-2464.
45. Husson, I., Rangon, C. M., Lelievre, V., Bemelmans, A. P., Sachs, P., Mallet, J., et al. (2005). BDNF-induced white matter neuroprotection and stage-dependent neuronal survival following a neonatal excitotoxic challenge. Cerebral Cortex, 15, 250-261.
46. Ikeda, K., Klinkosz, B., Greene, T., Cedarbaum, J. M., Wong, V., Lindsay, R. M., et al. (1995). Effects of brain-derived neurotrophic factor on motor dysfunction in wobbler mouse motor neuron disease. Annals of Neurology, 37, 505-511.
47. Jiang, N., Chopp, M., Stein, D., & Feit, H. (1996). Progesterone is neuroprotective after transient middle cerebral artery occlusion in male rats. Brain Research, 735, 101-107. (Pubitemid 26336624)
48. Kang, S. K., Lee, D. H., Bae, Y. C., Kim, H. K., Baik, S. Y., & Jung, J. S. (2003). Improvement of neurological deficits by intracerebral transplantation of human adipose tissue-derived stromal cells after cerebral ischemia in rats. Experimental Neurology, 183, 355-366.
49. Kaplan, D. R., & Miller, F. D. (2000). Neurotrophin signal transduction in the nervous system. Current Opinion in Neurobiology, 10, 381-391.
50. Kaur, P., Jodhka, P. K, Underwood, W. A., Bowles, C. A., de Fiebre, N. C., de Fiebre, C. M., et al. (2007). Progesterone increases brain-derived neuroptrophic factor expression and protects against glutamate toxicity in a mitogen-activated protein kinase- and phosphoinositide-3 kinase-dependent manner in cerebral cortical explants. Journal of Neuroscience Research, 85, 2441-2449.
51. Koh, J. Y., Gwag, B. J., Lobner, D., & Choi, D. W. (1995). Potentiated necrosis of cultured cortical neurons by neurotrophins. Science, 268, 573-575.
52. Kokaia, Z., Andsberg, G., Yan, Q., & Lindvall, O. (1998). Rapid alterations of BDNF protein levels in the rat brain after focal ischemia: Evidence for increased synthesis and anterograde axonal transport. Experimental Neurology, 154, 289-301.
53. Kokaia, Z., Zhao, Q., Kokaia, M., Elmer, E., Metsis, M., Smith, M.-L., et al. (1995). Regulation of brain-derived neurotrophic factor gene expression after transient middle cerebral artery occlusion with and without brain damage. Experimental Neurology, 136, 73-88.
54. Kume, T., Kouchiyama, H., Kaneko, S.,Maeda, T., Kaneko, S., Akaike, A., et al. (1997). BDNF prevents NO mediated glutamate cytotoxicity in cultured cortical neurons. Brain Research, 756, 200-204. (Pubitemid 27241627)
55. Kurozumi, K., Nakamura, K., Tamiya, T., Kawano, Y., Kobune, M., Hirai, S., et al. (2004). BDNF gene-modified mesenchymal stem cells promote functional recovery and reduce infarct size in the rat middle cerebral artery occlusion model. Molecular Therapy, 9, 189-197.
56. Lee, J., Duan, W., & Mattson, M. P. (2002). Evidence that brain-derived neurotrophic factor is required for basal neurogenesis and mediates, in part, the enhancement of neurogenesis by dietary restriction in the hippocampus of adult mice. Journal of Neurochemistry, 82, 1367-1375.
57. Lee, T.-H., Yang, J.-T., Kato, H., Wu, J. H., & Chen, S.-T. (2004). Expression of brain-derived neurotrophic factor immunoreactivity andmRNAin the hippocampal CA1 and cortical areas after chronic ischemia in rats. Journal of Neuroscience Research, 76, 705-712.
58. Lindholm, D., Dechant, G., Heisenberg, C. P., & Thoenen, H. (1993). Brain-derived neurotrophic factor is a survival factor for cultured rat cerebellar granule neurons and protects them against glutamate-induced neurotoxicity. European Journal of Neuroscience, 5, 1455-1464.
59. Lindvall, O., Ernfors, P., Bengzon, J., Kokaia, Z., Smith, M.-L., Siesjo, B. K., et al. (1992). Differential regulation of mRNAs for nerve growth factor, brain-derived neurotrophic factor, and neurotrophin 3 in the adult rat brain following cerebral ischemia and hypoglycemic coma. Proceedings of the National Academy of Sciences USA, 89, 648-652.
60. Lockhart, E. M., Warner, D. S., Pearlstein, R. D., Penning, D. H., Mehrabani, S., & Boustany, R.-M. (2002). Allopregnanolone attenuates N-methyl-D-aspartateinduced excitotoxicity and apoptosis in the human NT2 cell line in culture. Neuroscience Letters, 328, 33-36.
61. Loddick, S. A.,&Rothwell, N. J. (1996). Neuroprotective effects of human recombinant interleukin-1 receptor antagonist in focal ischemia in the rat. Journal of Cerebral Blood Flow and Metabolism, 16, 932-940.
62. Loihl, A. K., Asensio, V., Campbell, I. L., & Murphy, S. (1999). Expression of nitric oxide synthase (NOS)-2 following permanent focal ischemia and the role of nitric oxide in infarct generation in male, female and NOS-2 gene-deficient mice. Brain Research, 830, 155-164.
63. Maclusky, N. J., Chalmers-Redman, R., Kay, G., Ju, W., Nethrapalli, I. S., & Tatton, W. G. (2003). Ovarian steroids reduce apoptosis induced by trophic insufficiency in nerve cells and axotomized rat facial motoneurons. Neuroscience, 118, 741-754.
64. Maisonpierre, P. C., Belluscio, L., Friedman, B., Alderson, R. F., Wiegand, S. J., Furth, M. E., et al. (1990). NT-3, BDNF, and NGF in the developing rat nervous system: Parallel as well as reciprocal patterns of expression. Neuron, 5, 501-509.
65. Martinez-Serrano, A., & Bjorklund, A. (1996). Protection of the neostriatum against excitotoxic damage by neurotrophin-producing, genetically modified neural stem cells. The Journal of Neuroscience, 16, 4604-4616.
66. Matsushima, K., Schmidt-Kastner, R., Hogan, M. J., & Hakim, A. M. (1998). Cortical spreading depression activates trophic factor expression in neurons and astrocytes and protects against subsequent focal brain ischemia. Brain Research, 807, 47-60.
67. Mattson, M. P., Lovell, M. A., Furukawa, K.,&Markesbery,W. R. (1995). Neurotrophic factors attenuate glutamate-induced accumulation of peroxides, elevation of intracellular Ca2+ concentration, and neurotoxicity and increase antioxidant enzyme activities in hippocampal neurons. Journal of Neurochemistry, 65, 1740-1751.
68. Medhurst, A. D., Harrison, D. C., Read, S. J., Campbell, C. A., Robbins, M. J., & Pangalos, M. N. (2000). The use of Taqman RT-PCR assays for semiquantitative analysis of gene expression in CNS tissues and disease models. Journal of Neuroscience Methods, 98, 9-20.
69. Metsis, M., Timmusk, T., Arenas, E., & Persson, H. (1993). Differential usage of multiple brain-derived neurotrophic factor promoters in the rat brain following neuronal activation. Proceedings of the National Academy of Sciences USA, 90, 8802-8806.
70. Moraĺy, G., Letechiṕya-Vallejo, G., Ĺopez-Loeza, E., Montes, P., Herńandez-Morales, L., & Cervantes, M. (2005). Post-ischemic administration of progesterone in rats exerts neuroprotective effects on the hippocampus. Neuroscience Letters, 382, 286-290.
71. Morita, K., & Her, S. (2008). Progesterone pretreatment enhances serotonin-stimulated BDNF gene expression in rat c6 glioma cells through production of 5alpha-reduced neurosteroids. Journal of Molecular Neuroscience, 34, 193-200.
72. Murphy, S. J., Littleton-Kearney, M. T., & Hurn, P. D. (2002). Progesterone administration during reperfusion, but not preischemia alone, reduces injury in ovariectomized rats. Journal of Cerebral Blood Flow and Metabolism, 22, 1181-1188.
73. Nomura, T., Honmou, O., Harada, K., Houkin, K., Hamada, H., & Kocsis, J. D. (2005). I.V. infusion of brain-derived neurotrophic factor gene-modified human mesenchymal stem cells protects against injury in a cerebral ischemia model in adult rat. Neuroscience, 136, 161-169.
74. Nygren, J., Kokaia, M., & Wieloch, T. (2006). Decreased expression of brain-derived neurotrophic factor in BDNF(+/-) mice is associated with enhanced recovery of motor performance and increased neuroblast number following experimental stroke. Journal of Neuroscience Research, 84, 626-631.
75. Pettus, E. H., Wright, D. W., Stein, D. G., & Hoffman, S. W. (2005). Progesterone treatment inhibits the inflammatory agents that accompany traumatic brain injury. Brain Research, Brain Research, 84, 112-119.
76. Phillips, H. S., Hains, J. M., Laramee, G. R., Rosenthal, A., & Winslow, J. W. (1990). Widespread expression of BDNF but not NT3 by target areas of basal forebrain cholinergic neurons. Science, 250, 290-294.
77. Prehn, J. H. (1996). Marked diversity in the action of growth factors on N-methyl-D-aspartate-induced neuronal degeneration. European Journal of Pharmacology, 306, 81-88.
78. Rickhag, M., Teilum, M., & Wieloch, T. (2007). Rapid and long-term induction of effector immediate early genes (BDNF, Neuritin andArc) in peri-infarct cortex and dentate gyrus after ischemic injury in rat brain. Brain Research, Brain Research, 203-210.
79. Rickhag, M., Wieloch, T., Gid̈o, G., Elḿer, E., Krogh, M., Murray, J., et al. (2006). Comprehensive regional and temporal gene expression profiling of the rat brain during the first 24 h after experimental stroke identifies dynamic ischemia-induced gene expression patterns, and reveals a biphasic activation of genes in surviving tissue. Journal of Neurochemistry, 96, 14-29.
80. Rothman, S., & Olney, J. W. (1986). Glutamate and the pathophysiology of hypoxic/ischemic brain damage. Annals of Neurology, 19, 105-111.
81. Samdani,A. F., Newcamp, C.,Resink, A., Facchinetti, F.,Hoffman,B. E., Dawson,V. L., et al. (1997).Differential susceptibility to neurotoxicity mediated by neurotrophins and neuronal nitric oxide synthase. The Journal of Neuroscience, 17, 4633-4641.
82. Sayeed, I.,Wali, B.,&Stein, D. G. (2007). Progesterone inhibits ischemic brain injury in a rat model of permanent middle cerebral artery occlusion. Restorative Neurology and Neuroscience, 25, 151-159.
83. Schabitz, W. R., Schwab, S., Spranger, M., & Hacke, W. (1997). Intraventricular brainderived neurotrophic factor reduces infarct size after focal cerebral ischemia in rats. Journal of Cerebral Blood Flow and Metabolism, 17, 500-506. Schabitz,W. R., Steigleder,T., Cooper-Kuhn, C. M., Schwab, S., Sommer, C., Schneider, A., et al. (2007). Intravenous brain-derived neurotrophic factor enhances poststroke sensorimotor recovery and stimulates neurogenesis. Stroke, 38, 2165-2172.
84. Segal, R. A., & Greenberg, M. E. (1996). Intracellular signaling pathways activated by neurotrophic factors. Annual Review of Neuroscience, 19, 463-489.
85. Shear, D. A., Galani, R., Hoffman, S. W., & Stein, D. G. (2002). Progesterone protects against necrotic damage and behavioral abnormalities caused by traumatic brain injury. Experimental Neurology, 178, 59-67.
86. Skaper, S. D., Floreani, M., Negro, A., Facci, L., & Giusti, P. (1998). Neurotrophins rescue cerebellar granule neurons from oxidative stress-mediated apoptotic death: Selective involvement of phosphatidylinositol 3-kinase and the mitogen-activated protein kinase pathway. Journal of Neurochemistry, 70, 1859-1868.
87. Stein, D. G. (2008). Progesterone exerts neuroprotective effects after brain injury. Brain Research Reviews, 57, 386-397.
88. Timmusk, T., Palm, K., Metsis, M., Reintam, T., Paalme, V., Saarma, M., et al. (1993). Multiple promoters direct tissue-specific expression of the rat BDNF gene. Neuron, 10, 475-489.
89. Tuszynski, M. H., Mafong, E., & Meyer, S. (1996). Central infusions of brain-derived neurotrophic factor and neurotrophin-4/5, but not nerve growth factor and neurotrophin-3, prevent loss of the cholinergic phenotype in injured adult motor neurons. Neuroscience, 71, 761-771.
90. Viviani, B., Bartesaghi, S., Corsini, E., Villa, P., Ghezzi, P., Garau, A., et al. (2005). Erythropoietin protects primary hippocampal neurons increasing the expression of brain-derived neurotrophic factor. Journal of Neurochemistry, 93, 412-421.
91. Widmer, H., Knusel, B., & Hefti, F. (1993). BDNF protection of basal forebrain cholinergic neurons after axotomy: Complete protection of p75NGFR-positive cells. Neuroreport, 4, 363-366.
92. Wong, J. K.,Kennedy, P. R.,&Belcher, S. M. (2001). Simplified serum- and steroid-free culture conditions for high-throughput viability analysis of primary cultures of cerebellar granule neurons. Journal of Neuroscience Methods, 110, 45-55.
93. Wu, X., Zhu, D., Jiang, X., Okagaki, P., Mearow, K., Zhu, G., et al. (2004). AMPA protects cultured neurons against glutamate excitotoxicity through a phosphatidylinositol 3-kinase-dependent activation in extracellular signal-regulated kinase to upregulate BDNF gene expression. Journal of Neurochemistry, 90, 807-818.
94. Xiao, G., Wei, J., Yan, W., Wang, W., & Lu, Z. (2008). Improved outcomes from the administration of progesterone for patients with acute severe traumatic brain injury: A randomized controlled trial. Critical Care, 12, R61.
95. Yamashita, K., Wiessner, C., Lindholm, D., Thoenen, H., & Hossmann, K. A. (1997). Post-occlusion treatment with BDNF reduces infarct size in a model of permanent occlusion of the middle cerebral artery in rat. Metabolic Brain Disease, 12, 271-280.
96. Yan, Q., Elliott, J., & Snider, W. D. (1992). Brain-derived neurotrophic factor rescues spinal motor neurons from axotomy-induced cell death. Nature, 360, 753-755. (Pubitemid 23012274)
97. Zhang, Y., & Pardridge, W. M. (2001). Conjugation of brain-derived neurotrophic factor to a blood-brain barrier drug targeting system enables neuroprotection in regional brain ischemia following intravenous injection of the neurotrophin. Brain Research, 889, 49-56. (Pubitemid 32146264)
98. Zhang, Y., & Pardridge,W.M. (2006). Blood-brain barrier targeting of BDNF improves motor function in ratswith middle cerebral artery occlusion. Brain Research, 1111, 227-229.
99. Zheng, Z., Lee, J. E., & Yenari, M. A. (2003). Stroke: Molecular mechanisms and potential targets for treatment. Current Molecular Medicine, 3, 361-372.
100. Zink, M., Otto, C., Z̈orner, B., Zacher, C., Schütz, G., Henn, F. A., et al. (2004). Reduced expression of brain-derived neurotrophic factor in mice deficient for pituitary adenylate cyclase activating polypeptide type-I-receptor. Neuroscience Letters, 360, 106-108.